Literature DB >> 7704892

Endemic mycoses in AIDS: a clinical review.

J Wheat1.   

Abstract

Histoplasmosis and coccidioidomycosis are serious opportunistic infections in patients with AIDS who reside in areas of endemicity of the United States and Central and South America. Blastomycosis, although less common, also must be recognized as an opportunistic infection in patients with AIDS. Prompt diagnosis requires knowledge of the clinical syndromes and diagnostic tests as well as a high index of suspicion. Histoplasmosis and blastomycosis respond well to antifungal treatment, but relapse is common without chronic suppressive therapy. Improvements in treatment are needed in coccidioidomycosis. Research is needed to identify preventive strategies for patients at risk. These strategies may include use of prophylactic antifungal therapy or vaccination.

Entities:  

Mesh:

Year:  1995        PMID: 7704892      PMCID: PMC172853          DOI: 10.1128/CMR.8.1.146

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  69 in total

1.  Histoplasmosis in the acquired immunodeficiency syndrome (AIDS).

Authors:  W D Rawlinson; D R Packham; F J Gardner; C MacLeod
Journal:  Aust N Z J Med       Date:  1989-12

2.  Disseminated histoplasmosis in a Danish patient with AIDS.

Authors:  E Smith; M Franzmann; L R Mathiesen
Journal:  Scand J Infect Dis       Date:  1989

3.  Disseminated histoplasmosis in patients with AIDS.

Authors:  S D Nightingale; J M Parks; S M Pounders; D K Burns; J Reynolds; J A Hernandez
Journal:  South Med J       Date:  1990-06       Impact factor: 0.954

4.  Diagnosis of systemic histoplasmosis in AIDS patients.

Authors:  A Anand
Journal:  South Med J       Date:  1993-07       Impact factor: 0.954

5.  Itraconazole therapy for chronic coccidioidal meningitis.

Authors:  R M Tucker; D W Denning; B Dupont; D A Stevens
Journal:  Ann Intern Med       Date:  1990-01-15       Impact factor: 25.391

6.  Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group.

Authors:  J N Galgiani; A Catanzaro; G A Cloud; J Higgs; B A Friedman; R A Larsen; J R Graybill
Journal:  Ann Intern Med       Date:  1993-07-01       Impact factor: 25.391

7.  Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.

Authors:  J Wheat; R Hafner; M Wulfsohn; P Spencer; K Squires; W Powderly; B Wong; M Rinaldi; M Saag; R Hamill; R Murphy; P Connolly-Stringfield; N Briggs; S Owens
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

8.  Blastomycosis in immunocompromised patients.

Authors:  P G Pappas; M G Threlkeld; G D Bedsole; K O Cleveland; M S Gelfand; W E Dismukes
Journal:  Medicine (Baltimore)       Date:  1993-09       Impact factor: 1.889

9.  Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome.

Authors:  S Norris; J Wheat; D McKinsey; D Lancaster; B Katz; J Black; M Driks; R Baker; K Israel; D Traeger
Journal:  Am J Med       Date:  1994-06       Impact factor: 4.965

10.  Histoplasmosis in patients with acquired immunodeficiency syndrome. Hematologic and bone marrow manifestations.

Authors:  P J Kurtin; D S McKinsey; M R Gupta; M Driks
Journal:  Am J Clin Pathol       Date:  1990-03       Impact factor: 2.493

View more
  29 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Disseminated histoplasmosis presenting as multiple oral ulcers.

Authors:  Nicholas Hendren; Christina Yek; Jason Mull; James B Cutrell
Journal:  BMJ Case Rep       Date:  2017-07-14

3.  Unusual orofacial manifestations of histoplasmosis in renal transplanted patient.

Authors:  Ana Carolina F Motta; Rodrigo Galo; Alan Grupioni Lourenço; Marilena C Komesu; Darlene Arruda; Fabiana Guerra Velasco; Beatriz C Garcia; Norma T Foss
Journal:  Mycopathologia       Date:  2006-03       Impact factor: 2.574

Review 4.  Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis.

Authors:  K N Sorensen; K V Clemons; D A Stevens
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

5.  Molecular detection of Histoplasma capsulatum var. capsulatum in human clinical samples.

Authors:  Andrea Bracca; María Elena Tosello; Javier E Girardini; Susana L Amigot; Carlos Gomez; Esteban Serra
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

6.  Relatedness analyses of Histoplasma capsulatum isolates from Mexican patients with AIDS-associated histoplasmosis by using histoplasmin electrophoretic profiles and randomly amplified polymorphic DNA patterns.

Authors:  M R Reyes-Montes; M Bobadilla-Del Valle; M A Martínez-Rivera; G Rodríguez-Arellanes; E Maravilla; J Sifuentes-Osornio; M L Taylor
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

7.  Implementation of a Training Course Increased the Diagnosis of Histoplasmosis in Colombia.

Authors:  Diego H Caceres; Alejandra Zuluaga; Karen Arango-Bustamante; Catalina de Bedout; Ángela Maria Tobón; Ángela Restrepo; Beatriz L Gómez; Luz Elena Cano; Ángel González
Journal:  Am J Trop Med Hyg       Date:  2015-06-29       Impact factor: 2.345

Review 8.  Diagnosis of histoplasmosis: current status and perspectives.

Authors:  María Agustina Toscanini; Alejandro David Nusblat; María Luján Cuestas
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-15       Impact factor: 4.813

Review 9.  Current and emerging azole antifungal agents.

Authors:  D J Sheehan; C A Hitchcock; C M Sibley
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 10.  Perforation of the nasal septum as the first sign of histoplasmosis associated with AIDS and review of published literature.

Authors:  Angel Jaimes; Sandra Muvdi; Zulma Alvarado; Gerzaín Rodríguez
Journal:  Mycopathologia       Date:  2013-05-10       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.